EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY 4.0

Does the interval from melphalan administration to infusion of hematopoietic stem cells affect outcomes after autologous transplantation in multiple myeloma?

Viktoria Weihermann, Paulo Victor Rabelo Barbosa, Maria Eduarda Alonso Joaquim de Carvalho, Sabrina Maria Corrêa Brant Pereira de Jesus, José Vivaldo Moreira Feitosa Júnior, Vinicius Burnett Aboud Souza da Eira, Martha Mariana de Almeida Santos Arruda, Volney Assis Lara Vilela, André Domingues Pereira

Hematology, Transfusion and Cell Therapy · 2026-10 · 48 (4) · 106533

DOI: 10.1016/j.htct.2026.106533 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Hematology, Transfusion and Cell Therapy, 2026-10. Verfasst von Viktoria Weihermann und 8 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Cardiologia e Transplantes do Distrito Federal, Brasília, Brazil. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Instituto de Cardiologia e Transplantes do Distrito Federal, Brasília, Brazil.
  • Instituto de Cardiologia e Transplantes do Distrito Federal, Brasília, Brazil. Electronic address: pvrabelo1605@gmail.com.

Zitieren

APA

Weihermann, V., Barbosa, P. V. R., de Carvalho, M. E. A. J., de Jesus, S. M. C. B. P., Júnior, J. V. M. F., da Eira, V. B. A. S., Arruda, M. M. A. S., Vilela, V. A. L., & Pereira, A. D. (2026). Does the interval from melphalan administration to infusion of hematopoietic stem cells affect outcomes after autologous transplantation in multiple myeloma?. Hematology, Transfusion and Cell Therapy, 48(4), 106533. https://doi.org/10.1016/j.htct.2026.106533

Vancouver

Weihermann V, Barbosa PVR, de Carvalho MEAJ, de Jesus SMCBP, Júnior JVMF, da Eira VBAS, et al. Does the interval from melphalan administration to infusion of hematopoietic stem cells affect outcomes after autologous transplantation in multiple myeloma?. Hematology, Transfusion and Cell Therapy. 2026;48(4):106533. doi:10.1016/j.htct.2026.106533

BibTeX
@article{Weihermann2026,
  author = {Weihermann, Viktoria and Barbosa, Paulo Victor Rabelo and de Carvalho, Maria Eduarda Alonso Joaquim and de Jesus, Sabrina Maria Corrêa Brant Pereira and Júnior, José Vivaldo Moreira Feitosa and da Eira, Vinicius Burnett Aboud Souza and Arruda, Martha Mariana de Almeida Santos and Vilela, Volney Assis Lara and Pereira, André Domingues},
  title = {Does the interval from melphalan administration to infusion of hematopoietic stem cells affect outcomes after autologous transplantation in multiple myeloma?},
  journal = {Hematology, Transfusion and Cell Therapy},
  year = {2026},
  volume = {48},
  number = {4},
  pages = {106533},
  doi = {10.1016/j.htct.2026.106533}
}
Kostenlos starten →